Subcutaneous ureteral bypass for treatment of proximal ureteral obstruction secondary to retroperitoneal fibrosis after renal transplantation in a cat
View abstract on PubMed
Summary
This summary is machine-generated.This case study details a cat with chronic kidney disease that underwent renal transplantation. A subcutaneous ureteral bypass (SUB) device was used to manage ureteral obstruction in the transplanted kidney, marking a novel approach in feline veterinary medicine.
Area Of Science
- Veterinary Medicine
- Nephrology
- Surgical Innovation
Background
- A domestic shorthair cat with a 2-year history of chronic kidney disease underwent orthotopic renal transplantation.
- Post-transplantation complications included hydronephrosis and hydroureter, necessitating a neoureterocystostomy for ureteral stricture.
Observation
- Recurrent obstruction, hydronephrosis, and azotemia occurred 12 months post-transplantation, attributed to retroperitoneal fibrosis and adhesions.
- A subcutaneous ureteral bypass (SUB) device was surgically placed to manage the ureteral obstruction in the transplanted kidney.
Findings
- The SUB device provided temporary relief, but occlusion due to catheter kinking required replacement at 15 months.
- Despite interventions, renal function ultimately deteriorated, leading to euthanasia 28 months after SUB placement.
Implications
- This report highlights the first documented use of a SUB device for ureteral obstruction in a feline renal transplant recipient.
- While offering a potential solution, the case underscores challenges in long-term management and device patency in this complex clinical scenario.

